New injection aims to help when antidepressants fail
Disease control
Completed
This early-stage study tested a new drug called ALA-3000 in 37 adults with treatment-resistant depression — meaning their depression did not get better with standard antidepressants. Participants received either ALA-3000 injections or a placebo, along with a newly started oral an…
Phase: PHASE1 • Sponsor: Alar Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC